Welcome to our dedicated page for Aeluma SEC filings (Ticker: ALMU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aeluma's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aeluma's regulatory disclosures and financial reporting.
Aeluma, Inc. (ALMU) Form 144 reports a proposed sale of 150,000 common shares on NASDAQ through Oppenheimer & Co., with an aggregate market value of $2,827,312.50 based on the filing. The shares represent part of a 15,795,467-share outstanding base and are scheduled for sale on 08/14/2025. The filer acquired these shares in a private placement from the issuer on 10/27/2020 and paid for them in full on that date. The filing indicates no securities sold by the filer in the prior three months and includes the standard attestation that the seller is not aware of undisclosed material adverse information.
Aeluma's Chief Financial Officer, Christopher P. Stewart, reported direct beneficial ownership of equity awards consisting of 110,000 stock options with an exercise price of $21.04 and 55,000 restricted stock units (RSUs). The options vest 25% after 12 months then monthly over 36 months and expire 10 years after the vesting date. The RSUs vest 25% after the first fiscal quarter following the 12-month anniversary, then quarterly thereafter, and each RSU converts to one share at settlement.
Aeluma, Inc. appointed Christopher Stewart as full-time Chief Financial Officer and Principal Accounting Officer effective August 4, 2025. Stewart replaces interim CFO James Seo and brings prior public-company CFO experience at LeddarTech and Bionano Genomics and senior financial leadership roles at Maxwell Technologies, Entropic Communications and Intel. The company will enter into a standard indemnification agreement with him.
Stewart's compensation includes an annual salary of $300,000, an option to purchase 110,000 shares under the 2021 Stock Incentive Plan and 55,000 restricted stock units subject to the Plan. The employment agreement is attached as Exhibit 10.1 and a press release announcing the appointment is filed as Exhibit 99.1. The filing states no family relationships or transactions requiring Item 404 disclosure.